These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23684360)

  • 1. Alpha-fetoprotein surge following high-dose chemotherapy in germ cell tumours.
    Burgio SL; Menna C; Papiani G; Casadei Gardini A; De Luigi N; Corsi R; Rosti G
    J Chemother; 2013 Apr; 25(2):119-22. PubMed ID: 23684360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical outcomes in patients with primary mediastinal non-seminomatous germ cell tumours and elevated post-chemotherapy serum tumour markers.
    De Latour B; Fadel E; Mercier O; Mussot S; Fabre D; Fizazi K; Dartevelle P
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):66-71; discussion 71. PubMed ID: 22290909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary mediastinal germ cell tumor with marked elevation of HCG and alpha-fetoprotein].
    Nakagawa Y; Kuwahara O; Nakaoka K; Dohi H; Hanada M
    Nihon Kyobu Geka Gakkai Zasshi; 1987 Mar; 35(3):381-6. PubMed ID: 2439616
    [No Abstract]   [Full Text] [Related]  

  • 4. Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?
    Banna GL; De Giorgi U; Ferrari B; Castagna L; Alloisio M; Marangolo M; Rosti G; Santoro A
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1085-91. PubMed ID: 17084372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of patients with residual germ cell or non-germ cell malignancy after resection of primary mediastinal nonseminomatous germ cell cancer.
    Schneider BP; Kesler KA; Brooks JA; Yiannoutsos C; Einhorn LH
    J Clin Oncol; 2004 Apr; 22(7):1195-200. PubMed ID: 15051766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticators.
    Deville JL; Gravis G; Salem N; Savoie PH; Esterni B; Walz J; Thomas P; Goncalves A; Viens P; Bladou F
    Eur J Cancer Care (Engl); 2010 Nov; 19(6):827-32. PubMed ID: 19708949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Germ cell testicular tumors: understanding the kinetics of serum alpha-fetoprotein (AFP) during chemotherapy].
    Riedinger JM; Eche N; Chevreau C; Fargeot P
    Ann Biol Clin (Paris); 2008; 66(5):523-30. PubMed ID: 18957341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer.
    Rick O; Bokemeyer C; Weinknecht S; Schirren J; Pottek T; Hartmann JT; Braun T; Rachud B; Weissbach L; Hartmann M; Siegert W; Beyer J
    J Clin Oncol; 2004 Sep; 22(18):3713-9. PubMed ID: 15365067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
    Gerl A; Lamerz R; Clemm C; Mann K; Hartenstein R; Wilmanns W
    Clin Cancer Res; 1996 Sep; 2(9):1565-70. PubMed ID: 9816334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-line high-dose chemotherapy combined with peripheral blood stem cell transplantation for patients with advanced extragonadal germ cell tumors.
    Kumano M; Miyake H; Hara I; Furukawa J; Takenaka A; Fujisawa M
    Int J Urol; 2007 Apr; 14(4):336-8. PubMed ID: 17470166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable hematopoietic recovery after peripheral blood stem cell transplantation in patients receiving high-dose chemotherapy for advanced germ cell tumors.
    Kumano M; Miyake H; Hara I; Furukawa J; Takenaka A; Fujisawa M
    Anticancer Res; 2006; 26(6C):4965-8. PubMed ID: 17214371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resection of residual pulmonary masses after chemotherapy in patients with metastatic non-seminomatous germ cell tumours.
    Horvath LG; McCaughan BC; Stockle M; Boyer MJ
    Intern Med J; 2002 Mar; 32(3):79-83. PubMed ID: 11885847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Embryonal carcinoma and vitelline tumor of the mediastinum. Diagnostic and prognostic value of alpha-fetoprotein levels. A propos of 5 cases].
    Vincent M; Gamondes JP; Loire R; Lasne Y; Bechet MC; Brune J
    Rev Fr Mal Respir; 1983; 11(1):19-29. PubMed ID: 6189155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alphafetoprotein and germ cell neoplasms.
    Hayatnagarkar NP; Deshpande AD; Solanki BR
    Indian J Med Res; 1980 Aug; 72():269-72. PubMed ID: 6164638
    [No Abstract]   [Full Text] [Related]  

  • 16. Regression pattern of alpha fetoprotein level changed after treatment of malignant germ cell tumor.
    Sanersak S; Prueksritanond N
    J Med Assoc Thai; 2008 Mar; 91(3):287-94. PubMed ID: 18575279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: results of a multicentre study. Report from the Medical Research Council Working Party on Testicular Tumours.
    Lancet; 1985 Jan; 1(8419):8-11. PubMed ID: 2578205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful resection of a giant mediastinal non-seminomatous germ cell tumor showing fluorodeoxyglucose accumulation after neoadjuvant chemotherapy: report of a case.
    Takada K; Morodomi Y; Okamoto T; Suzuki Y; Fujishita T; Kitahara H; Shimamatsu S; Kohno M; Kawano D; Hidaka N; Nakanishi Y; Maehara Y
    Fukuoka Igaku Zasshi; 2014 May; 105(5):117-23. PubMed ID: 25283008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
    Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
    J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can a cure be achieved with taxane-based chemotherapy plus surgery in patients with primary mediastinal non-seminomatous germ cell tumors and progression or relapse despite first-line chemotherapy?
    Miskovska V; Levy A; Massard CC; Gross-Goupil M; Bossi A; Fizazi K
    Onkologie; 2010; 33(3):119-20. PubMed ID: 20215805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.